About Aspicio Therapeutics
Aspicio Therapeutics is a private company based in Downingtown, Pennsylvania, incorporated in 2024 in Delaware. It has reported $600,000 raised in two offerings on Form D since June 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Jul 17, 2026 | $200,000fully sold | 2 | $100K | DebtRule 506(b) | Form D ↗ |
| Jun 18, 2024 | Jun 21, 2024 | $400,000fully sold | 3 | $133K | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $600,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Aspicio Therapeutics's Form D filed Jul 17, 2026.
MK
Michael Keane
President and director